Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by Exchange Traded Concepts LLC

Posted by Defense World Staff on Oct 7th, 2023

Exchange Traded Concepts LLC increased its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 23.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,485 shares of the company’s stock after acquiring an additional 6,018 shares during the period. Exchange Traded Concepts LLC’s holdings in Pediatrix Medical Group were worth $447,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Pacer Advisors Inc. acquired a new position in Pediatrix Medical Group in the first quarter worth approximately $12,439,000. Norges Bank acquired a new position in Pediatrix Medical Group in the fourth quarter worth approximately $11,064,000. Lazard Asset Management LLC grew its position in Pediatrix Medical Group by 24.3% in the first quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock worth $76,631,000 after buying an additional 637,798 shares during the last quarter. ArrowMark Colorado Holdings LLC grew its position in Pediatrix Medical Group by 11.2% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 4,048,957 shares of the company’s stock worth $60,168,000 after buying an additional 407,239 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Pediatrix Medical Group by 8.6% in the first quarter. Dimensional Fund Advisors LP now owns 3,861,170 shares of the company’s stock worth $57,569,000 after buying an additional 306,469 shares during the last quarter. 96.89% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com initiated coverage on Pediatrix Medical Group in a research note on Thursday. They issued a “hold” rating on the stock. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average price target of $16.60.

View Our Latest Stock Report on Pediatrix Medical Group

Pediatrix Medical Group Trading Down 0.7 %

Shares of NYSE MD opened at $12.89 on Friday. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.71. Pediatrix Medical Group, Inc. has a one year low of $12.23 and a one year high of $19.63. The business has a 50-day moving average price of $13.58 and a two-hundred day moving average price of $13.89. The firm has a market capitalization of $1.08 billion, a PE ratio of 10.39, a PEG ratio of 1.97 and a beta of 1.71.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.40 by ($0.01). Pediatrix Medical Group had a return on equity of 12.81% and a net margin of 5.16%. The company had revenue of $500.60 million for the quarter, compared to analyst estimates of $495.88 million. During the same quarter in the prior year, the business posted $0.43 earnings per share. The business’s revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.43 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.